Lilly & Co. (LLY), AstraZeneca (AZN) Enter co-Development Agreement Covering AZD3293
Tweet Send to a Friend
Lilly & Co. (NYSE: LLY) and AstraZeneca (NYSE: AZN) announced an agreement to co-develop and commercialize AZD3293, an oral beta ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
